drugset / Trial / NCT00036816
Vaccine Therapy in Treating Patients With Melanoma of the Eye
RandomizedTreatment
Summary
RATIONALE: Vaccines may make the body build an immune response to kill tumor cells and decrease the recurrence of melanoma of the eye. PURPOSE: Randomized phase III trial to determine the effectiveness of vaccine therapy in treating patients who are at high risk for recurrent melanoma of the eye.
Timeline
- Start
- 2002-02
- Primary completion
- 2003-02
- Completion
- —
Outcome
Outcome not reported
Stopped (Enrollment): “low accrual”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MART-1 | Peptide | — | Subcutaneous |
| Subject | NA17-A | Vaccine | — | Subcutaneous |
| Subject | gp100 | Vaccine | — | Subcutaneous |
| Subject | tyrosinase | Peptide | — | Subcutaneous |